Dispatch #6
Illustration for Week 40: The Conviction-Accuracy Gap Widens

Week 40: The Conviction-Accuracy Gap Widens

The conviction engine fired seven new positions totaling $5,000 across Intel and Palantir while closing Moderna for +11.16%, but the week exposed a critical structural flaw: directional accuracy on BUY/SELL calls remains unreliable across all names. Intel dominated coverage with 143 articles yet delivered only 50% accuracy on one-day directional predictions, while Palantir—the week's highest-conviction signal at 11.0—carries just 17% accuracy on resolved calls. The portfolio now holds eight open positions resolving Oct 6-9, all dependent on ordinary drift rather than earnings catalysts, the regime where the engine performs worst.

Week 40 marked the third consecutive week of aggressive capital deployment, with the engine opening seven positions across two AI-infrastructure names. Intel absorbed four $1,000 BUY signals despite coverage fragmentation—143 articles generated conviction but failed to produce coherent directional guidance, evidenced by the 50% hit rate on one-day SELL calls. Palantir emerged as the week's conviction leader at 11.0 on 31 articles, triggering two $500 positions, but the engine's historical accuracy on PLTR remains deeply concerning: 17% on resolved BUY/SELL calls, rising to 80% only when HOLD signals—which carry no timing risk—are included in the blend.

The week's sole closed position, Moderna, delivered the largest single-trade gain to date: +$111.59 on a $1,000 stake. The outcome appears to validate the engine's conviction framework, but stripping out the win rate reveals the same accuracy problem: MRNA's directional calls resolved correctly just 14% of the time across seven signals. The engine is capturing momentum, not predicting it. This distinction becomes load-bearing as the portfolio enters a stretch with no earnings catalysts—eight positions now resolve Oct 6-9 on ordinary drift, the condition under which conviction-outcome disagreement has been most pronounced.

Concentration risk has escalated to a structural concern. Intel now represents four open positions totaling $4,000, or 80% of deployed capital, with all four resolving within a three-day window. A single adverse move in INTC would mark the second consecutive week where high conviction failed to translate into directional accuracy, warranting a formal review of conviction thresholds before new capital deploys.

Portfolio Highlights

INTC BUY High

Intel absorbed 143 articles and triggered four $1,000 BUY positions, but the conviction score masked weak directional guidance: one-day SELL calls resolved at 50% accuracy. The engine is betting on momentum continuation into Oct 6-9 resolution dates, but the timing reliability remains unproven. Single-name concentration now represents the portfolio's largest structural risk.

PLTR BUY High

Palantir closed the week as the highest-conviction name at 11.0 on 31 articles, driving two $500 positions. The signal strength is undeniable, but the engine's historical accuracy on PLTR BUY/SELL calls is just 17% when HOLD signals are excluded. The Oct 7-8 resolution window will test whether conviction and timing have converged.

MRNA BUY Medium

Moderna closed for +$111.59 (+11.16%), the largest single-trade gain in the paper portfolio's history. The win validates the engine's ability to capture momentum, but the underlying directional accuracy—14% across seven resolved calls—suggests the engine is riding trends rather than predicting them. The distinction matters as catalysts thin out.

Outlook

The next seven days represent a critical test of the engine's timing reliability. Eight positions resolve Oct 6-9 on ordinary drift rather than earnings catalysts, the condition where conviction-outcome disagreement has been most pronounced. Intel's four-position cluster creates binary risk: a single adverse move would erase the week's gains and force a formal review of conviction thresholds. Palantir's 17% directional accuracy and Plug Power's 0% rate suggest the engine has not yet earned the confidence its conviction scores imply. Base case: the portfolio delivers positive returns on momentum continuation, but the probability of a red close has elevated meaningfully. A second consecutive week of conviction-accuracy divergence would warrant tightening signal filters before new capital deploys.

This commentary is generated by an AI system analysing quantitative trading data. It does not constitute financial advice. Past performance does not guarantee future results.